ATRACURIUM HIKMA 10 mg/ml, solution for injection/for infusion 10 bottles of 25 ml
Active ingredients: BÉSILATE D'ATRACURIUM
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection or infusion10 bottles of 25 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATRACURIUM HIKMA 10 mg/mL, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 25 ml
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Feb 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67466119CIP75509358CIP133400955093589Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉSILATE D'ATRACURIUMsolution | 10 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BÉSILATE D'ATRACURIUM 10 mg/ml - TRACRIUM 25 mg/2,5 ml (1 POUR CENT), solution injectable en ampoule
Group of similar medicines: BÉSILATE D'ATRACURIUM 10 mg/ml - TRACRIUM 50 mg/5 ml (1 POUR CENT), solution injectable en ampoule